(Q40475844)

20 September 2017

1 reference

title

Epstein-Barr virus as an agent of haematological disease. (English)

1 reference

20 September 2017

0 references

4

1 reference

20 September 2017

Tosato G

1

1 reference

PubMed ID

7663046

20 September 2017

Taga K

series ordinal

2

1 reference

PubMed ID

7663046

20 September 2017

Angiolillo AL

series ordinal

3

1 reference

20 September 2017

1 March 1995

1 reference

Best Practice and Research: Clinical Haematology

20 September 2017

1 reference

20 September 2017

8

1 reference

20 September 2017

1

1 reference

20 September 2017

165-199

1 reference

Human B-lymphotropic virus (human herpesvirus-6).

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Pleural effusions in congestive heart failure and in pericardial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus in the bone marrow of patients with aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

The serological diagnosis of glandular fever (infectious mononucleosis): a new technique

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8) and t(8;22) translocations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Human herpesvirus-6 (HHV-6, HBLV) in sarcoidosis and lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Presenting Clinical Features of Burkitt's Lymphoma in Ghana, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Lymphoma of host origin in a marrow transplant recipient in remission of acute myeloid leukemia and receiving cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Severe chronic EBV infection associated with specific EBV immunodeficiency and an EBNA+ T-cell lymphoma containing linear, EBV DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Burkitt's lymphoma: a model for clinical oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Auto Anti-N Immunohemolytic Anemia in Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Immunoregulation during acute infection with Epstein-Barr virus: dynamics of interferon and 2',5'-oligoadenylate synthetase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Determining the Climatic Limitations of a Children's Cancer Common in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Studies on infectious mononucleosis. IV. Changes in the granulocytic series

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Antibody to Herpesvirus hominis types 1 and 2 in patients with Hodgkin's disease and carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Intense jaundice in an adolescent. An unusual presentation of infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Infectious mononucleosis. The spectrum of morphologic changes simulating lymphoma in lymph nodes and tonsils

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

The seroepidemiology of human herpesvirus-6 (HHV-6) from a case-control study of leukaemia and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr Virus Lymphoproliferative Disease Associated with Acquired Immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

CHILDHOOD LYMPHOSARCOMA IN ST. LOUIS, MISSOURI, CLINICALLY AND HISTOLOGICALLY RESEMBLING BURKITT'S TUMOR

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Expression of B-cell-specific markers in different Burkitt lymphoma subgroups.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

T- and B-Cells in Peripheral Blood during Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Seroepidemiologic Studies of Infectious Mononucleosis with Eb Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

A Prospective Evaluation of Heterophile and Epstein-Barr Virus-Specific IgM Antibody Tests in Clinical and Subclinical Infectious Mononucleosis: Specificity and Sensitivity of the Tests and Persistence of Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr Virus Infections in Brazil. II. Hodgkin's Disease2

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

A mechanism of T cell regulation of Epstein-Barr virus latency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Association of EB-virus infection with the post-perfusion syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Viral involvement in Hodgkin's disease: detection of clonal type A Epstein-Barr virus genomes in tumour samples

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoid cell lines and in the blood of patients with infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Surface immunoglobulins on Burkitt's lymphoma biopsy cells from 91 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Observations on childhood infections with the Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus specific diagnostic tests in infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

A case control study on immunity to two epstein-barr virus-associated antigens, and to herpes simplex virus and adenovirus in a population-based group of patients with hodgkin's disease in denmark, 1971–73

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

EBV gene expression in an NPC-related tumour.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Acquired immunodeficiency syndrome-associated lymphomas: clinical, pathologic, immunologic, and viral characteristics of 111 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

INFECTIOUS MONONUCLEOSIS: AN UNSUSPECTED SOURCE ON ANTI-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

AIDS-associated non-Hodgkin's lymphoma in San Francisco

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Simultaneous presence of EBNA-positive and colony-forming cells in peripheral blood of patients with infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Agranulocytosis Following Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Viral latency and transformation: the strategy of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Antibodies to Epstein-Barr virus, cytomegalovirus, and Australia antigen in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Replication of EBV in epithelial cells during infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Development of B-cell lymphoma in homosexual men. Clinical and immunologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Retrovirus and malignant lymphoma in homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus infection and replication in a human epithelial cell system

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Chronic lymphoproliferative disorders: classification and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus in AIDS-related primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B-cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Marker band in one chromosome 14 from Burkitt lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Alternative involvement of two cytogenetically distinguishable breakpoints on chromosome 8 in Burkitt's lymphoma associated translocations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Anginose Type of Infectious Mononucleosis Requiring Tracheostomy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Atypical infectious mononucleosis with bone marrow granulomas and pancytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

The switch between latency and replication of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Expression of CD45R0 (UCHL1) by CD4+ and CD8+ T cells as a sign of in vivo activation in infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

1 reference

7 January 2021

Site of Epstein-Barr virus replication in the oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Immunohistological studies of lymphoproliferative lesions in a fatal case of Epstein-Barr virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Thymic lesions in fatal infectious mononucleosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Cyclosporin A immunosuppression, Epstein-Barr antibody, and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus antibody in cases and contacts of infectious mononucleosis; a family study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

CHILDHOOD LYMPHOMA RESEMBLING "BURKITT TUMOR" IN THE UNITED STATES

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus and human diseases: recent advances in diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Cytotoxic Effector Cells from Infectious Mononucleosis Patients in the Acute Phase Do Not Specifically Kill Epstein-Barr Virus Genome-Carrying Lymphoid Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Cancers following cyclosporine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Variable Phenotypic Expression of an X-Linked Recessive Lymphoproliferative Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Quantitative Evaluation of Epstein-Barr-Virus-Infected Mononuclear Peripheral Blood Leukocytes in Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Rupture of the spleen in infectious mononucleosis: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Jaw involvement in American Burkitt's Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Antineutrophil antibodies in infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Molecular genetic analysis of post-transplant lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Cancer after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Thymic origin of atypical lymphoid cells in infectious mononucleosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Replication of Epstein–Barr virus in human epithelial cells infected in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

A second site for Epstein-Barr virus shedding: the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Detection of a second widespread strain of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Infection surveillance in cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Acute Progressive Epstein-Barr Virus Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus-associated peripheral T-cell lymphoma of activated CD8 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr-virus induced lymphoproliferation. Implications for antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Detection of Epstein-Barr viral DNA in aggressive CD8+ T cell leukaemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Post‐transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Early events in Epstein-Barr virus infection provide a model for B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Interleukin-6 production in posttransplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Human virus-infected target cells lacking HLA antigens resist specific T-lymphocyte cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Fatal Aplastic Anaemia Complicating Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Lymphoma in cardiac allotransplant recipients. Clinical and histological features and immunological phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Natural history of severe thrombocytopenia in infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Burkitt's tumour in england a comparison with childhood lymphosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

AIRWAY OBSTRUCTION IN INFECTIOUS MONONUCLEOSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980237-9

7 January 2021

10.1016/S0950-3536(05)80237-9

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7663046